GLIMECHECK MF 1/850

Glimecheck MF 1/850 Tablet is a combination of two trusted antidiabetic agents: Glimepiride 1 mg and Metformin Hydrochloride 850 mg. This formulation offers enhanced glycemic control in patients with Type 2 Diabetes Mellitus, especially those who need a higher dose of Metformin to manage their blood sugar levels.

• Glimepiride stimulates insulin release from pancreatic beta cells.

• Metformin 850 mg reduces glucose production in the liver and improves insulin sensitivity in the body.

This powerful combination helps patients achieve better control over their fasting and post-meal blood glucose levels while reducing the risk of long-term diabetic complications.

Key Benefits:

• Higher dose of Metformin for more effective sugar control

• Combines insulin stimulation and insulin sensitivity improvement

• Reduces HbA1c levels when used regularly

• Supports overall metabolic health in Type 2 Diabetes